Remote Drug Payer Economics Evaluator

IXO is seeking a U.S.-based payer or market-access professional for paid remote expert evaluation of commercial medicines and drug-development programs. The work applies practical reimbursement and managed-market experience to the assumptions used in those assessments.

The role focuses on evaluating and critiquing rubrics, setting gross-to-net assumptions by drug class, and testing payer-oriented logic to ensure credible, market-aligned conclusions across medicines and drug classes.